I think we partially answered that question. There are several aspects to the signature initiative. It's the initiative I talked about on personalized medicine that is co-funded with Genome Canada.
I must add, talking about leveraging—I had a question on leveraging—that we're investing at the federal level $67.5 million. That's leveraged 50% by the provinces and the private sector. It's enormous. We're talking about doubling our investment to $135 million.
As you heard, what we're trying to do with this initiative is not only foster basic research to help us develop some genetic profiles for new diseases and a variety of disorders, but also to start thinking about the ethical issues linked with personalized medicine, linked with the cost of personalized medicine, and about how we're going to deal with that. We are looking at how are we going to ensure that what we're gaining in terms of quality of care is counterbalanced by affordability of care as well.